Eosinophils contribute to inflammatory bowel disease (IBD) pathogenesis by infiltrating the intestinal mucosa and releasing pro-inflammatory mediators, including eosinophilic cationic protein (ECP). Here, RNASE3 is linked to inflammatory bowel disease.